Works matching IS 17762596 AND DT 2014 AND VI 9 AND IP 3
Results: 11
In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 225, doi. 10.1007/s11523-013-0285-6
- By:
- Publication type:
- Article
Curcumin induces apoptosis of HepG2 cells via inhibiting fatty acid synthase.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 279, doi. 10.1007/s11523-013-0286-5
- By:
- Publication type:
- Article
A phase l study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumors.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 215, doi. 10.1007/s11523-013-0288-3
- By:
- Publication type:
- Article
Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 195, doi. 10.1007/s11523-013-0289-2
- By:
- Publication type:
- Article
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 239, doi. 10.1007/s11523-013-0290-9
- By:
- Publication type:
- Article
Anti-Sp17 monoclonal antibody-doxorubicin conjugates as molecularly targeted chemotherapy for ovarian carcinoma.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 263, doi. 10.1007/s11523-013-0293-6
- By:
- Publication type:
- Article
Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 251, doi. 10.1007/s11523-013-0294-5
- By:
- Publication type:
- Article
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 273, doi. 10.1007/s11523-013-0299-0
- By:
- Publication type:
- Article
New agents in renal cell carcinoma.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 183, doi. 10.1007/s11523-013-0303-8
- By:
- Publication type:
- Article
Diagnostic challenges of respiratory adverse events during everolimus treatment.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 287, doi. 10.1007/s11523-014-0310-4
- By:
- Publication type:
- Article
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 3, p. 205, doi. 10.1007/s11523-013-0284-7
- By:
- Publication type:
- Article